Leadership Overview
Mars Veterinary has 4 executives leading key functions including global financial strategy, regional financial operations, clinical medical standards, and external medical affairs.
Driven by a commitment to pet wellbeing, Mars Veterinary advances global veterinary health through scientific innovation, data-driven clinical excellence, and the support of thousands of dedicated veterinary professionals across thousands of international clinics.
Driven by a commitment to pet wellbeing, Mars Veterinary advances global veterinary health through scientific innovation, data-driven clinical excellence, and the support of thousands of dedicated veterinary professionals across thousands of international clinics.
Leadership Roles at Mars Veterinary
Ted Stedem - Global Chief Financial Officer, Mars Veterinary Health
Ted Stedem, the Global Chief Financial Officer, Mars Veterinary Health at Mars Veterinary, directs the entire financial architecture for the global organization. Managing capital allocation across 3,000 clinics, Stedem ensures fiscal health while supporting the expansion of preventive and specialty care services. The Global Chief Financial Officer, Mars Veterinary Health oversees long-term investment strategies that fuel technological breakthroughs and data-driven clinical advancements. By aligning financial resources with the mission of improving pet health, Stedem optimizes operational efficiency across diverse international markets. This leadership role involves close collaboration with the board to maintain sustainable growth and profitability. Ted Stedem monitors global economic trends to mitigate risks and capitalize on emerging opportunities within the veterinary sector. Through rigorous financial oversight, Stedem secures the necessary funding to empower 70,000 associates in delivering high-quality care to pets worldwide.

Tatsuhiko Miyamoto - Chief Financial Officer, At Vca (Japan)
Tatsuhiko Miyamoto, the Chief Financial Officer, At Vca (Japan) at Mars Veterinary, manages all financial operations and fiscal planning within the Japanese market. Overseeing regional revenue streams, the Chief Financial Officer, At Vca (Japan) ensures that local clinics maintain the high standards of preventive and emergency care synonymous with the global brand. Miyamoto directs budget allocation to support the integration of advanced veterinary technologies and data systems across the Japanese network. By analyzing regional market performance, Miyamoto drives strategic initiatives that enhance operational efficiency and clinic profitability. This role requires constant coordination with global leadership to ensure alignment with overarching corporate objectives. Tatsuhiko Miyamoto monitors local regulatory environments and economic shifts to maintain financial stability. Through precise fiscal management, Miyamoto supports the expansion of veterinary services, ultimately contributing to the broader mission of creating a better world for pets and the people who care for them.
Molly McAllister - Chief Medical Officer
Molly McAllister, the Chief Medical Officer at Mars Veterinary, architects the clinical standards and medical protocols utilized across the global network of 3,000 clinics. Leading the development of preventive and specialty care guidelines, the Chief Medical Officer ensures that 12,000 veterinarians deliver consistent, high-quality treatment. McAllister leverages extensive data and scientific research to drive innovation in veterinary medicine, improving health outcomes for pets on a massive scale. By fostering a culture of continuous learning, McAllister supports the professional development of veterinary teams. This leadership role involves collaborating with technology partners to integrate advanced diagnostic tools into daily practice. Molly McAllister monitors clinical performance metrics to identify areas for improvement and excellence. Through the implementation of evidence-based medicine, McAllister strengthens the organization's market position as a leader in veterinary health, ensuring that every pet receives compassionate and effective care.

Todd Tams - Chief Medical Officer, External Affairs
Todd Tams, the Chief Medical Officer, External Affairs at Mars Veterinary, manages relationships with academic institutions, veterinary associations, and industry partners to advance the field of veterinary medicine. Overseeing external communications regarding clinical breakthroughs, the Chief Medical Officer, External Affairs ensures that the organization remains at the forefront of scientific discourse. Tams directs initiatives that promote the importance of preventive care and emergency preparedness within the broader veterinary community. By representing the company in professional forums, Tams influences industry standards and advocates for the wellbeing of pets and veterinary professionals. This role involves bridging the gap between internal clinical research and external stakeholders to foster collaborative innovation. Todd Tams coordinates with global leadership to align external messaging with the company's mission of improving pet health. Through strategic engagement, Tams enhances the reputation of the organization, ensuring that scientific advancements reach the wider veterinary profession effectively.
Explore Leadership Teams in Business Services
Los Alamos National Laboratory, a multidisciplinary research institution engaged in strategic science on behalf of national security, is operated by Triad, a public service oriented, national security science organization equally owned by its three founding members: Battelle Memorial Institute (Battelle), the Texas A&M University System (TAMUS), and the Regents of the University of California (UC) for the Department of Energy's National Nuclear Security Administration. Los Alamos enhances national security by ensuring the safety and reliability of the U.S. nuclear stockpile, developing technologies to reduce threats from weapons of mass destruction, and solving problems related to energy, environment, infrastructure, health, and global security concerns.
Company Leadership GW
GW
MC
The National Laboratory of the Rockies, located in Golden, Colorado, is a national laboratory of the United States Department of Energy specializing in energy systems research and development. Formerly known as the National Renewable Energy Laboratory until December 2025, NLR serves as the primary federal laboratory for advancing energy technologies across the entire energy spectrum, from generation to distribution to end use. The laboratory conducts multidisciplinary research in renewable energy, energy efficiency, energy systems integration, sustainable transportation, bioenergy, photovoltaics, wind energy, hydrogen and fuel cells, energy storage, and advanced materials science. NLR operates state-of-the-art research facilities including the Energy Systems Integration Facility, Solar Energy Research Facility, and maintains high-performance computing capabilities. The laboratory partners with industry, government agencies, academia, and other national laboratories to bridge foundational research with practical applications. NLR develops data sets, analytical tools, and models for energy technology analysis while working to lower energy costs, drive economic growth, strengthen national security, and ensure abundant energy for the nation. The laboratory maintains campuses in Golden and Arvada, Colorado, as well as Fairbanks, Alaska, and is operated under contract for the Department of Energy's Office of Critical Minerals and Energy Innovation by the Alliance for Sustainable Energy.
Company Leadership GH
TH

LabConnect provides global central laboratory and client-inspired support services for logistically and analytically complex studies, routine testing, kit building, sample management and tracking, data management, biorepository and scientific functional outsourcing for biopharmaceutical and CRO clients. It offers a complete range of innovative project and data management services that connect high-quality samples to accurate data-and that can be customized to meet the unique needs of clients and their clinical studies. LabConnect's unique combination of state-of-the-art technology, world-class laboratories, and easy access to major and emerging markets means that drug development companies can rely on one preeminent provider for their central laboratory and preclinical through Phase IV clinical development needs.
Company Leadership RH
)
RL
Founded in 1940, Department of Energy - Argonne National Laboratory is a science and engineering research national laboratory that specializes in energy, global security, and energy systems. Department of Energy - Argonne National Laboratory is located in Illinois.
Company Leadership MC
DR
MS
DR